Novel approach for enhancing atrioventricular nodal conduction delay mediated by endogenous adenosine.
Cynthia Kollias-Baker(University of Florida), Luiz Belardinelli(Acorda Therapeutics (United States)), Jian Xu(University of California, Los Angeles), Amir Pelleg(Hahnemann University Hospital)
Cited by 22
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial
|Journal of Nuclear Cardiology|2007|345
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245